Polichem S.A.   Report issue

For profit Phase 3
Founded: Lugano Switzerland (1946)
Status: Acquired by Almirall (2015)

Organization Overview

First Clinical Trial
2014
NCT02547701
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Polichem SA

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 3)

Alopecia Areata (Phase 3)

Onychomycosis (Phase 3)

Photosensitivity Disorders (Phase 1)

Psoriasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 4